-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
-
Summary
-
Orchard Therapeutics plc quarterly/annual Deferred Income Tax Expense (Benefit) history and growth rate from Q1 2021 to Q1 2023.
- Orchard Therapeutics plc Deferred Income Tax Expense (Benefit) for the quarter ending March 31, 2023 was $242K, a 69.3% decline year-over-year.
- Orchard Therapeutics plc annual Deferred Income Tax Expense (Benefit) for 2022 was -$3.28M, a 390% decline from 2021.
- Orchard Therapeutics plc annual Deferred Income Tax Expense (Benefit) for 2021 was $1.13M.
- Orchard Therapeutics plc annual Deferred Income Tax Expense (Benefit) for 2020 was -$2.26M, a 23.3% increase from 2019.
Deferred Income Tax Expense (Benefit), Quarterly (USD)
Deferred Income Tax Expense (Benefit), YoY Quarterly Growth (%)